Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, as it prepares to launch its popular ...
On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...
The forecast comes weeks after the drugmaker stunned investors with weaker-than-expected sales for its weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback